ADAM17 and type 1 diabetes mellitus: In people with type 1 diabetes, these synergies may reduce or suppress TNF-α and IFN-γ levels.This may be because flavonoids block the tumor necrosis factor-alpha-converting enzyme (TACE), which lowers the amount of TNF-αproduced by NK cells.